IL273507A
(en )
2020-05-31
Methods, devices and systems for pulmonary delivery of active agents
IL276695B
(en )
2021-09-30
Antibodies, pharmaceutical compositions and uses thereof
DK3332767T3
(en )
2019-06-24
Liquid inhalation formulation comprising RPL554
DK3569222T3
(en )
2024-08-19
Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
DK3107548T3
(en )
2022-07-18
DRY POWDER FORMULATIONS FOR INHALATION
DK3325059T3
(en )
2021-05-03
DRY POWDER INHALATOR
DK3505209T3
(en )
2020-12-21
POWDER INHALATOR
SG11201608943VA
(en )
2016-11-29
Substituted 4-phenylpiperidines, their preparaiton and use
ZA201902762B
(en )
2020-10-28
Mission-critical push-to-talk
DK3620176T3
(en )
2021-09-20
A process for the preparation of a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
DK3129006T3
(en )
2021-04-19
Immunosuppressive formulation
HK1256674A1
(en )
2019-10-04
Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
DK3138600T3
(en )
2020-02-03
The dry powder inhaler
DK3689379T3
(en )
2021-09-06
A process for the preparation of a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
PL3040062T3
(en )
2018-02-28
Absorbent structure, and absorbent item comprising this absorbent structure
PL3256154T3
(en )
2021-07-19
Pharmaceutical formulation comprising antibody
DK3179986T3
(en )
2023-05-01
DRY POWDER FORMULATIONS FOR INHALATION
IL249773A0
(en )
2017-02-28
Dry powder medicament de-agglomerator
BR112016025075A2
(en )
2018-05-15
agrochemical formulation.
SG11201700276QA
(en )
2017-02-27
Quinoxaline compounds, method for preparing the same and use thereof
DK2915526T3
(en )
2021-09-06
PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
GB201409603D0
(en )
2014-07-16
An inhalable medicament
FR3021118B1
(en )
2018-03-16
SUPERCONDUCTING COMPONENT, AMPLIFIER
TH1601000099A
(en )
2017-01-18
Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation.
DK3212212T3
(en )
2020-12-21
POWDER FORMULATION